Warfarin sodium and Fluid retention - from FDA reports


Summary

Fluid retention is found among people who take Warfarin Sodium, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Furosemide, and have Primary pulmonary hypertension . We study 50,578 people who have side effects while taking Warfarin sodium from FDA. Among them, 286 have Fluid retention. Find out below who they are, when they have Fluid retention and more.

What to expect?

If you take Warfarin sodium and have Fluid retention, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Warfarin sodium and have Fluid retention

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 54,018 users)

Fluid Retention

Fluid retention (an abnormal accumulation of fluid in the blood) has been reported by people with primary pulmonary hypertension, pulmonary hypertension, high blood pressure, diabetes, multiple sclerosis (latest reports from 35,419 Fluid retention patients).

On Jan, 28, 2017

50,578 people reported to have side effects when taking Warfarin Sodium.
Among them, 286 people (0.57%) have Fluid Retention


Number of reports submitted per year:

Could Warfarin sodium cause Fluid retention?

Time on Warfarin Sodium when people have Fluid Retention *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Fluid Retention when taking Warfarin Sodium *:

  • female: 56.43 %
  • male: 43.57 %

Age of people who have Fluid Retention when taking Warfarin Sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.41 %
  • 20-29: 0.82 %
  • 30-39: 2.86 %
  • 40-49: 9.8 %
  • 50-59: 24.08 %
  • 60+: 62.04 %

Top conditions involved for these people *:

  • Primary Pulmonary Hypertension (42 people, 14.69%)
  • Metastases To Bone (24 people, 8.39%)
  • Atrial Fibrillation/flutter (21 people, 7.34%)
  • Pulmonary Hypertension (19 people, 6.64%)
  • Depression (14 people, 4.90%)

Top co-used drugs for these people *:

  • Furosemide (80 people, 27.97%)
  • Digoxin (66 people, 23.08%)
  • Lasix (57 people, 19.93%)
  • Simvastatin (39 people, 13.64%)
  • Celebrex (39 people, 13.64%)

Top other side effects for these people *:

  • Breathing Difficulty (69 people, 24.13%)
  • Weight Increased (65 people, 22.73%)
  • Cardiac Failure Congestive (55 people, 19.23%)
  • Anaemia (48 people, 16.78%)
  • Nausea (44 people, 15.38%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Fluid retention when taking Warfarin sodium?

Browse all side effects of Warfarin sodium

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Fluid retention

Fluid retention

Could your condition cause Fluid retention

Fluid retention

Related studies

Can you answer these questions?

More questions for: Warfarin sodium, Fluid retention

You may be interested in these reviews

More reviews for: Warfarin sodium, Fluid retention